CL

CLRB · CIK 0001279704

Cellectar Biosciences, Inc. (CLRB) SEC Filings

Browse 1208 SEC filings for Cellectar Biosciences, Inc., covering Jun 21, 2004 through Jul 10, 2026, organized by filing purpose with direct links to the original EDGAR documents.

NasdaqPharmaceutical PreparationsFiscal year end: 12-31View company on SEC.gov

Indexed filings

1,208

Filed in the last 12 months

50

History covered

20042026

Latest filing

4/A

Jul 10, 2026

Latest important filings

Jump directly to the most recent annual, quarterly, and current reports.

Latest annual report

10-K/A

Annual report · Apr 30, 2026

Open original filing

Latest quarterly report

10-Q

Quarterly report · May 14, 2026

Open original filing

Latest company update

8-K

Management or director change; Shareholder vote · Jul 10, 2026

Open original filing

Complete filing history

Search by form or description, filter by purpose and year, and open the original SEC document.

50 filings

All categories

Search by form or description, filter by purpose and year, and open the original SEC document.

50
FormDescriptionPeriod endedFiled
4/A
Amended
OWNERSHIP DOCUMENTJul 8, 2026Jul 10, 2026
8-KManagement or director change; Shareholder voteJul 7, 2026Jul 10, 2026
4OWNERSHIP DOCUMENTJul 7, 2026Jul 8, 2026
4OWNERSHIP DOCUMENTJul 7, 2026Jul 8, 2026
4OWNERSHIP DOCUMENTJul 7, 2026Jul 8, 2026
4OWNERSHIP DOCUMENTJul 7, 2026Jul 8, 2026
4OWNERSHIP DOCUMENTJul 7, 2026Jul 8, 2026
4OWNERSHIP DOCUMENTJul 7, 2026Jul 8, 2026
4OWNERSHIP DOCUMENTJul 7, 2026Jul 8, 2026
4OWNERSHIP DOCUMENTJul 7, 2026Jul 8, 2026
4OWNERSHIP DOCUMENTJul 8, 2026Jul 8, 2026
3OWNERSHIP DOCUMENTMay 18, 2026Jun 9, 2026
SCHEDULE 13GSCHEDULE 13G filingJun 5, 2026
424B3424B3 filingJun 2, 2026
EFFECTEFFECT filingJun 1, 2026
CORRESPCorrespondence with the SECMay 29, 2026
S-1/A
Amended
Securities registration statementMay 29, 2026
DEFA14AAdditional proxy materialsMay 28, 2026
DEF 14ADefinitive proxy statementJul 7, 2026May 28, 2026
UPLOADSEC staff correspondenceMay 22, 2026
S-1Securities registration statementMay 19, 2026
PRE 14APreliminary proxy statementMay 18, 2026May 18, 2026
8-KManagement or director changeMay 17, 2026May 18, 2026
8-KResults of operationsMay 14, 2026May 14, 2026
10-QQuarterly reportMar 31, 2026May 14, 2026

Page 1 of 2

Recent filing activity

Annual filing counts derived from this company's SEC history.

2026

36 filings

2025

62 filings

2024

56 filings

2023

51 filings

2022

50 filings

2021

65 filings

2020

76 filings

2019

66 filings

Sources and methodology

How this filing index is assembled and checked.

Filing metadata comes from SEC EDGAR submissions. Categories and plain-language labels are generated deterministically from SEC form and item codes; filing content is not summarized on this page.

Index updated: 7/15/2026

For research and education only. Always review the original SEC filing before making a decision.